ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666596 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666596; 2) Community: the network communities that were significantly associated with the response to NSC 666596; 3) Molecule: the relationships between components within communities and NSC 666596; 4) MDR: the compounds that were significantly associated with the NSC 666596.

NSC Compound Enrichment Correlation
NSC 758465 SALINOMYCIN, SODIUM 0.0247979034812111 0.032589881
NSC 760476 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione 0.0247979034812111 0.33064034
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0247979034812111 0.40551
NSC 117281 ANTINEOPLASTIC-117281 0.0267520285931239 0.36369915
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.0267520285931239 0.29949996
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.0267520285931239 0.30256904
NSC 321206 Null 0.0267520285931239 0.23002613
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.0267520285931239 0.45633071
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0267520285931239 0.20800598
NSC 623436 TGF.alpha.-PE40 0.0267520285931239 -0.10926597
Total:151  Current:98    [First] [Prev] [Next] [Last]